ACADACADIA PHARMACEUTICALS INCvs its industry peers
A metric-by-metric comparison of ACADIA PHARMACEUTICALS INC against SPDR S&P Biotech ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ACADEsta | $3.6B#11 | 9.3x#1 | 2.7x#1 | 3.3x#1 | 11.9%#4 | 73.0%#1 | 9.8%#1 | 29.9%#1 | 11.4%#1 | — | -7.3%#4 | — |
| MRNA | $92.5B#1 | — | 13.7x#9 | 47.6x#4 | -39.9%#6 | 20.8%#6 | -158.1%#4 | -41.7%#11 | -54.6%#4 | — | 830.5%#1 | — |
| TWST | $8.8B#5 | — | 19.7x#12 | 23.3x#2 | 20.3%#3 | 62.8%#2 | -36.2%#2 | -17.4%#7 | -41.4%#3 | — | — | — |
| ORKA | $6.7B#7 | — | 6.0x#6 | — | — | -25.9%#8 | — | -9.5%#5 | — | — | — | — |
| KYMR | $11.0B#3 | — | 6.8x#7 | 279.8x#5 | -16.7%#5 | 39.1%#3 | -891.1%#5 | 19.3%#2 | — | — | — | — |
| VKTX | $3.4B#12 | — | 5.8x#4 | — | — | -227.1%#13 | — | -61.1%#13 | — | — | -26.0%#5 | — |
| PRAX | $7.9B#6 | — | 5.9x#5 | — | -100.0%#7 | -65.6%#10 | — | -22.6%#9 | — | — | — | — |
| ERAS | $5.2B#10 | — | 14.3x#10 | — | — | 23.0%#5 | — | -34.4%#10 | — | — | — | — |
| RVMD | $41.9B#2 | — | 16.1x#11 | — | — | -88.5%#12 | — | -43.4%#12 | — | — | 229.1%#3 | — |
| RYTM | $6.1B#8 | — | 69.0x#13 | 32.0x#3 | 45.8%#2 | 24.6%#4 | -101.2%#3 | -0.2%#4 | -127.5%#5 | — | — | — |
| CGON | $5.8B#9 | — | 5.7x#3 | 1439.7x#6 | 254.7%#1 | -82.9%#11 | -4722.1%#6 | -15.6%#6 | -18.8%#2 | — | — | — |
| SLS | $1.8B#13 | — | 12.9x#8 | — | -100.0%#7 | 13.0%#7 | — | -19.5%#8 | — | — | 390.0%#2 | — |
| PCVX | $9.1B#4 | — | 3.3x#2 | — | — | -65.2%#9 | — | -0.0%#3 | — | — | — | — |
Peer set: top holdings of XBI (SPDR S&P Biotech ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice